IBDEI2V9 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45724,1,3,0)
 ;;=3^Toxic Effect,Wasps,Sequela
 ;;^UTILITY(U,$J,358.3,45724,1,4,0)
 ;;=4^T63.461S
 ;;^UTILITY(U,$J,358.3,45724,2)
 ;;=^5053548
 ;;^UTILITY(U,$J,358.3,45725,0)
 ;;=T88.6XXA^^172^2277^7
 ;;^UTILITY(U,$J,358.3,45725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45725,1,3,0)
 ;;=3^Anaphylactic Reaction,Drug/Med,1st Encntr
 ;;^UTILITY(U,$J,358.3,45725,1,4,0)
 ;;=4^T88.6XXA
 ;;^UTILITY(U,$J,358.3,45725,2)
 ;;=^5055808
 ;;^UTILITY(U,$J,358.3,45726,0)
 ;;=T88.6XXD^^172^2277^9
 ;;^UTILITY(U,$J,358.3,45726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45726,1,3,0)
 ;;=3^Anaphylactic Reaction,Drug/Med,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,45726,1,4,0)
 ;;=4^T88.6XXD
 ;;^UTILITY(U,$J,358.3,45726,2)
 ;;=^5055809
 ;;^UTILITY(U,$J,358.3,45727,0)
 ;;=T88.6XXS^^172^2277^8
 ;;^UTILITY(U,$J,358.3,45727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45727,1,3,0)
 ;;=3^Anaphylactic Reaction,Drug/Med,Sequela
 ;;^UTILITY(U,$J,358.3,45727,1,4,0)
 ;;=4^T88.6XXS
 ;;^UTILITY(U,$J,358.3,45727,2)
 ;;=^5055810
 ;;^UTILITY(U,$J,358.3,45728,0)
 ;;=J45.20^^172^2277^49
 ;;^UTILITY(U,$J,358.3,45728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45728,1,3,0)
 ;;=3^Asthma,Mild Intermittent,Uncompl
 ;;^UTILITY(U,$J,358.3,45728,1,4,0)
 ;;=4^J45.20
 ;;^UTILITY(U,$J,358.3,45728,2)
 ;;=^5008242
 ;;^UTILITY(U,$J,358.3,45729,0)
 ;;=J45.21^^172^2277^47
 ;;^UTILITY(U,$J,358.3,45729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45729,1,3,0)
 ;;=3^Asthma,Mild Intermittent w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,45729,1,4,0)
 ;;=4^J45.21
 ;;^UTILITY(U,$J,358.3,45729,2)
 ;;=^5008243
 ;;^UTILITY(U,$J,358.3,45730,0)
 ;;=J45.22^^172^2277^48
 ;;^UTILITY(U,$J,358.3,45730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45730,1,3,0)
 ;;=3^Asthma,Mild Intermittent w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,45730,1,4,0)
 ;;=4^J45.22
 ;;^UTILITY(U,$J,358.3,45730,2)
 ;;=^5008244
 ;;^UTILITY(U,$J,358.3,45731,0)
 ;;=J45.30^^172^2277^52
 ;;^UTILITY(U,$J,358.3,45731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45731,1,3,0)
 ;;=3^Asthma,Mild Persistent,Uncomp
 ;;^UTILITY(U,$J,358.3,45731,1,4,0)
 ;;=4^J45.30
 ;;^UTILITY(U,$J,358.3,45731,2)
 ;;=^5008245
 ;;^UTILITY(U,$J,358.3,45732,0)
 ;;=J45.31^^172^2277^50
 ;;^UTILITY(U,$J,358.3,45732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45732,1,3,0)
 ;;=3^Asthma,Mild Persistent w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,45732,1,4,0)
 ;;=4^J45.31
 ;;^UTILITY(U,$J,358.3,45732,2)
 ;;=^5008246
 ;;^UTILITY(U,$J,358.3,45733,0)
 ;;=J45.32^^172^2277^51
 ;;^UTILITY(U,$J,358.3,45733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45733,1,3,0)
 ;;=3^Asthma,Mild Persistent w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,45733,1,4,0)
 ;;=4^J45.32
 ;;^UTILITY(U,$J,358.3,45733,2)
 ;;=^5008247
 ;;^UTILITY(U,$J,358.3,45734,0)
 ;;=J45.40^^172^2277^55
 ;;^UTILITY(U,$J,358.3,45734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45734,1,3,0)
 ;;=3^Asthma,Moderate Persistent,Uncomp
 ;;^UTILITY(U,$J,358.3,45734,1,4,0)
 ;;=4^J45.40
 ;;^UTILITY(U,$J,358.3,45734,2)
 ;;=^5008248
 ;;^UTILITY(U,$J,358.3,45735,0)
 ;;=J45.41^^172^2277^53
 ;;^UTILITY(U,$J,358.3,45735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45735,1,3,0)
 ;;=3^Asthma,Moderate Persistent w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,45735,1,4,0)
 ;;=4^J45.41
 ;;^UTILITY(U,$J,358.3,45735,2)
 ;;=^5008249
 ;;^UTILITY(U,$J,358.3,45736,0)
 ;;=J45.42^^172^2277^54
